Compare $FBLG vs $SNGX | Chartloom

Compare

$FBLG vs $SNGX

Fibrobiologics Inc · Soligenix Inc

FBLG

Fibrobiologics Inc

SNGX

Soligenix Inc

Compare $FBLG vs $SNGX

Comparing Fibrobiologics Inc and Soligenix Inc

FBLGFibrobiologics Inc

SNGXSoligenix Inc

FBLGFibrobiologics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.4%

52W performance

-88.8%

FCF yield

-215.4%

SNGXSoligenix Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.4%

52W performance

-79.9%

FCF yield

-180.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBLG

SNGX

Detailed metrics comparison

FBLG

Fibrobiologics Inc

SNGX

Soligenix Inc

Market Cap

FBLG$7M

SNGX$5M

Enterprise Value

FBLG$3M

SNGX$-4M

Price

FBLG$1.13

SNGX$0.36

P/E Ratio

FBLGN/A

SNGXN/A

P/S Ratio

FBLG0.00x

SNGX16.09x

EV/Sales

FBLG0.00x

SNGX-3.76x

EV/EBITDA

FBLG0.00x

SNGX-1.54x

P/B Ratio

FBLG1.78x

SNGX1.20x

P/FCF Ratio

FBLGN/A

SNGXN/A

EV/FCF

FBLG-0.24x

SNGX0.45x

PEG Ratio

FBLGN/A

SNGXN/A

Forward P/E (NTM)

FBLGN/A

SNGXN/A

Forward P/S (NTM)

FBLGN/A

SNGXN/A

Revenue (TTM)

FBLG$0

SNGX$0

Revenue Growth (YoY)

FBLGN/A

SNGXN/A

Forward Rev Growth

FBLG227.6%

SNGX0.0%

Gross Margin (TTM)

FBLG0.0%

SNGX8.8%

Operating Margin (TTM)

FBLG0.0%

SNGX0.0%

EBITDA Margin (TTM)

FBLG0.0%

SNGX0.0%

Net Margin (TTM)

FBLG0.0%

SNGX0.0%

FCF Margin (TTM)

FBLGN/A

SNGXN/A

Net Income (TTM)

FBLG$-18M

SNGX$-10M

FCF (TTM)

FBLG$-15M

SNGX$-10M

EPS (TTM)

FBLG-$2.89

SNGX-$0.64

ROE (TTM)

FBLG-53678.0%

SNGX-18102.0%

ROA (TTM)

FBLG-22512.0%

SNGX-10792.0%

ROIC (TTM)

FBLG-39304.0%

SNGX-18102.0%

Cash

FBLG$4M

SNGX$10M

Debt

FBLG$124K

SNGX$0

Net Cash/Debt

FBLG$3M

SNGX$10M

Current Ratio (TTM)

FBLG2.64x

SNGX2.77x

Quick Ratio (TTM)

FBLG2.40x

SNGX2.67x

Debt/Equity (TTM)

FBLG0.03x

SNGX0.00x

Debt/Assets (TTM)

FBLG0.0%

SNGX0.0%

Interest Coverage (TTM)

FBLGN/A

SNGXN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

SNGX0.00x

Beta

FBLG1.79

SNGX2.15

52W Performance

FBLG-88.8%

SNGX-79.9%

YTD Performance

FBLG-76.4%

SNGX-74.4%

% from 52W High

FBLG-89.0%

SNGX-81.5%

% from 52W Low

FBLG82.3%

SNGX29.9%

Asset Turnover (TTM)

FBLG0.00x

SNGX0.05x

FCF Yield (TTM)

FBLG-215.4%

SNGX-180.8%

Earnings Yield (TTM)

FBLG-264.0%

SNGX-190.0%

Dividend Yield (TTM)

FBLGN/A

SNGXN/A

Rule of 40

FBLG0.0

SNGX0.0

EV/GP/RG

FBLGN/A

SNGXN/A

Ticker research

View FBLG research View SNGX research

Metric	FBLG Fibrobiologics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$3M	$-4M
Price	$1.13	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	1.78x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	227.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-10M
FCF (TTM)	$-15M	$-10M
EPS (TTM)	-$2.89	-$0.64
ROE (TTM)	-53678.0%	-18102.0%
ROA (TTM)	-22512.0%	-10792.0%
ROIC (TTM)	-39304.0%	-18102.0%
Financial Health
Cash	$4M	$10M
Debt	$124K	$0
Net Cash/Debt	$3M	$10M
Current Ratio (TTM)	2.64x	2.77x
Quick Ratio (TTM)	2.40x	2.67x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	2.15
52W Performance	-88.8%	-79.9%
YTD Performance	-76.4%	-74.4%
% from 52W High	-89.0%	-81.5%
% from 52W Low	82.3%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-215.4%	-180.8%
Earnings Yield (TTM)	-264.0%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBLG research	View SNGX research

Valuation

P/S Ratio

FBLG

0.00x

SNGX

16.09x

EV/FCF

FBLG

-0.24x

SNGX

0.45x

Growth & revenue

Forward Revenue Growth

FBLG

227.6%

SNGX

0.0%

Profitability & performance

Gross Margin

SNGX

8.8%

FBLG

0.0%

ROE

SNGX

-18102.0%

FBLG

-53678.0%

FCF Yield %

SNGX

-180.8%

FBLG

-215.4%

52-Week Performance

SNGX

-79.9%

FBLG

-88.8%

Detailed metrics comparison

FBLG

Fibrobiologics Inc

SNGX

Soligenix Inc

Market Cap

FBLG$7M

SNGX$5M

Enterprise Value

FBLG$3M

SNGX$-4M

Price

FBLG$1.13

SNGX$0.36

P/E Ratio

FBLGN/A

SNGXN/A

P/S Ratio

FBLG0.00x

SNGX16.09x

EV/Sales

FBLG0.00x

SNGX-3.76x

EV/EBITDA

FBLG0.00x

SNGX-1.54x

P/B Ratio

FBLG1.78x

SNGX1.20x

P/FCF Ratio

FBLGN/A

SNGXN/A

EV/FCF

FBLG-0.24x

SNGX0.45x

PEG Ratio

FBLGN/A

SNGXN/A

Forward P/E (NTM)

FBLGN/A

SNGXN/A

Forward P/S (NTM)

FBLGN/A

SNGXN/A

Revenue (TTM)

FBLG$0

SNGX$0

Revenue Growth (YoY)

FBLGN/A

SNGXN/A

Forward Rev Growth

FBLG227.6%

SNGX0.0%

Gross Margin (TTM)

FBLG0.0%

SNGX8.8%

Operating Margin (TTM)

FBLG0.0%

SNGX0.0%

EBITDA Margin (TTM)

FBLG0.0%

SNGX0.0%

Net Margin (TTM)

FBLG0.0%

SNGX0.0%

FCF Margin (TTM)

FBLGN/A

SNGXN/A

Net Income (TTM)

FBLG$-18M

SNGX$-10M

FCF (TTM)

FBLG$-15M

SNGX$-10M

EPS (TTM)

FBLG-$2.89

SNGX-$0.64

ROE (TTM)

FBLG-53678.0%

SNGX-18102.0%

ROA (TTM)

FBLG-22512.0%

SNGX-10792.0%

ROIC (TTM)

FBLG-39304.0%

SNGX-18102.0%

Cash

FBLG$4M

SNGX$10M

Debt

FBLG$124K

SNGX$0

Net Cash/Debt

FBLG$3M

SNGX$10M

Current Ratio (TTM)

FBLG2.64x

SNGX2.77x

Quick Ratio (TTM)

FBLG2.40x

SNGX2.67x

Debt/Equity (TTM)

FBLG0.03x

SNGX0.00x

Debt/Assets (TTM)

FBLG0.0%

SNGX0.0%

Interest Coverage (TTM)

FBLGN/A

SNGXN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

SNGX0.00x

Beta

FBLG1.79

SNGX2.15

52W Performance

FBLG-88.8%

SNGX-79.9%

YTD Performance

FBLG-76.4%

SNGX-74.4%

% from 52W High

FBLG-89.0%

SNGX-81.5%

% from 52W Low

FBLG82.3%

SNGX29.9%

Asset Turnover (TTM)

FBLG0.00x

SNGX0.05x

FCF Yield (TTM)

FBLG-215.4%

SNGX-180.8%

Earnings Yield (TTM)

FBLG-264.0%

SNGX-190.0%

Dividend Yield (TTM)

FBLGN/A

SNGXN/A

Rule of 40

FBLG0.0

SNGX0.0

EV/GP/RG

FBLGN/A

SNGXN/A

Ticker research

View FBLG research View SNGX research

Metric	FBLG Fibrobiologics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$3M	$-4M
Price	$1.13	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	16.09x
EV/Sales	0.00x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	1.78x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.24x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	227.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-10M
FCF (TTM)	$-15M	$-10M
EPS (TTM)	-$2.89	-$0.64
ROE (TTM)	-53678.0%	-18102.0%
ROA (TTM)	-22512.0%	-10792.0%
ROIC (TTM)	-39304.0%	-18102.0%
Financial Health
Cash	$4M	$10M
Debt	$124K	$0
Net Cash/Debt	$3M	$10M
Current Ratio (TTM)	2.64x	2.77x
Quick Ratio (TTM)	2.40x	2.67x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	2.15
52W Performance	-88.8%	-79.9%
YTD Performance	-76.4%	-74.4%
% from 52W High	-89.0%	-81.5%
% from 52W Low	82.3%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-215.4%	-180.8%
Earnings Yield (TTM)	-264.0%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBLG research	View SNGX research